Medical services

Prevention is most valuable when it is based on an individual’s actual risk rather than the same screening approach for everyone. European prevention guidelines recommend systematic assessment of blood pressure, lipids, smoking, glucose, weight, family history and overall cardiovascular risk, so that interventions are proportional to the expected benefit. The American Heart Association’s Life’s Essential 8 likewise highlights nutrition, physical activity, sleep, avoidance of smoking, and control of weight, cholesterol, glucose and blood pressure. A structured check-up helps identify silent risk factors early, update appropriate vaccinations and develop a realistic follow-up plan.

Arterial hypertension often causes no symptoms, but it substantially increases the risk of myocardial infarction, stroke, heart failure and kidney disease. The ESC and ESH emphasize accurate confirmation of the diagnosis with both office and out-of-office measurements, assessment for target-organ damage, and investigation of secondary causes when indicated. Twenty-four-hour ambulatory monitoring can identify masked or white-coat hypertension and characterize the nocturnal blood-pressure profile. In the landmark SPRINT trial, more intensive systolic blood-pressure control in selected high-risk patients reduced major cardiovascular events. Treatment targets are individualized according to age, comorbidities and tolerability.

Atherosclerosis develops over many years before symptoms appear. LDL-C is a causal factor in atherosclerotic cardiovascular disease, which is why contemporary ESC/EAS guidelines base treatment intensity on overall risk and the required LDL-C level. Lp(a) is now recognized as an important risk modifier, while triglycerides and other metabolic factors complete the risk profile. Trials such as FOURIER have shown that further LDL-C reduction with PCSK9 inhibition can reduce cardiovascular events in high-risk patients. Appropriate risk stratification helps avoid both undertreatment and unnecessary overtreatment.

Diabetes mellitus is not only about blood glucose; it is a disease with major cardiovascular, renal and metabolic consequences. The ADA Standards of Care 2026 recommend individualized glycemic targets together with management of blood pressure, lipids, weight, kidney function and overall cardiovascular risk. Modern treatment is selected not only according to HbA1c, but also according to the presence of atherosclerotic disease, heart failure or chronic kidney disease. EMPA-REG OUTCOME was one of the trials that changed clinical practice by demonstrating cardiovascular benefit beyond glycemic control. The aim is long-term organ protection, not simply achieving a “good” glucose number.

Obesity is recognized as a chronic, relapsing disease rather than simply a matter of willpower or appearance. The European EASO framework recommends assessment of the overall burden: metabolic, cardiovascular, mechanical and psychosocial complications, together with individualized treatment. Management may include nutritional and behavioral interventions, physical activity, pharmacotherapy and, when indicated, referral for bariatric/metabolic surgery. SELECT, involving 17,604 people with overweight or obesity and established cardiovascular disease without diabetes, showed a reduction in major cardiovascular events with semaglutide. Safe weight management requires long-term follow-up and goals that extend beyond the number on the scale.

PrEP is one of the most effective strategies for preventing HIV infection when prescribed appropriately and accompanied by systematic follow-up. The EACS Guidelines 2025 incorporate contemporary PrEP options and emphasize HIV testing before initiation, assessment of kidney function and hepatitis B where required, and regular STI screening. iPrEx was the landmark randomized trial that established the efficacy of oral PrEP and showed that protection is closely linked to adherence. In parallel, European IUSTI guidelines support targeted diagnosis and treatment of sexually transmitted infections. The consultation is an opportunity for comprehensive, confidential sexual healthcare without stigma.

Healthy-ageing medicine does not mean unproven “anti-ageing” treatments. The strongest scientific evidence concerns long-term control of the factors that determine cardiovascular and metabolic health: blood pressure, lipids, glucose, weight, physical activity, nutrition, sleep and smoking. The American Heart Association’s Life’s Essential 8 and ESC prevention guidelines organize these goals into measurable domains. In long-term population studies, combinations of adverse lifestyle habits have been associated with substantially higher mortality, while systematic lifestyle improvement is associated with better long-term health. The approach focuses on measurable goals, realistic interventions and periodic reassessment.

In adult infections, early recognition of serious illness is as important as avoiding unnecessary antibiotic treatment. ATS/IDSA guidelines for community-acquired pneumonia emphasize accurate diagnosis, severity assessment and treatment selection according to the clinical profile. Similarly, the EAU Guidelines 2026 for urinary tract infections update diagnostic and treatment criteria and incorporate antimicrobial-stewardship principles. Assessment includes symptoms, examination, risk factors, possible complications and the need for cultures or imaging. The goal is effective treatment when needed while limiting antimicrobial resistance and adverse effects.

Many chronic conditions progress silently and require consistent, coordinated follow-up rather than fragmented testing. KDIGO 2024 emphasizes staging chronic kidney disease with eGFR and albuminuria and using risk assessment to guide targeted monitoring. The European Thyroid Association publishes contemporary guidelines for the diagnosis and treatment of thyroid disorders, while the Endocrine Society emphasizes fracture-risk stratification and reassessment of osteoporosis treatment. Comprehensive Internal Medicine follow-up helps coordinate investigations, medications and comorbidities safely and recognize early when specialist referral is needed.

A medical certificate is not merely an administrative process; it is a medical act that should be based on an adequate history, clinical examination and, when indicated, targeted testing. For fitness-for-sport certification, the ESC Guidelines on Sports Cardiology support assessment of individual cardiovascular risk and evaluation of symptoms or findings that warrant further investigation, rather than indiscriminate testing of everyone in the same way. The type of assessment depends on age, exercise intensity, medical history and comorbidities. Likewise, every medical report should describe only what can be medically documented and should serve its specific purpose clearly and responsibly.